These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9695733)

  • 1. Bcl-2 slows in vitro breast cancer growth despite its antiapoptotic effect.
    Knowlton K; Mancini M; Creason S; Morales C; Hockenbery D; Anderson BO
    J Surg Res; 1998 Apr; 76(1):22-6. PubMed ID: 9695733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells.
    Niu MY; Ménard M; Reed JC; Krajewski S; Pratt MA
    Oncogene; 2001 Jun; 20(27):3506-18. PubMed ID: 11429697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation of Bax to mitochondria induces apoptotic cell death in indole-3-carbinol (I3C) treated breast cancer cells.
    Rahman KM; Aranha O; Glazyrin A; Chinni SR; Sarkar FH
    Oncogene; 2000 Nov; 19(50):5764-71. PubMed ID: 11126363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
    Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
    Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction.
    Zhang M; Chiu LC; Cheung PC; Ooi VE
    Oncol Rep; 2006 Mar; 15(3):637-43. PubMed ID: 16465424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells.
    Bélanger S; Côté M; Lane D; L'Espérance S; Rancourt C; Piché A
    Gynecol Oncol; 2005 Jun; 97(3):796-806. PubMed ID: 15913739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 induces genomic instability, BCL2 expression, doxorubicin resistance, and altered cancer-initiating cell phenotype in MCF7 breast cancer cells.
    Singh B; Cook KR; Vincent L; Hall CS; Berry JA; Multani AS; Lucci A
    J Surg Res; 2008 Jun; 147(2):240-6. PubMed ID: 18498876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy.
    Jezierska A; Matysiak W; Motyl T
    Med Sci Monit; 2006 Aug; 12(8):BR263-73. PubMed ID: 16865058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
    Fernández Y; España L; Mañas S; Fabra A; Sierra A
    Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profile and cell cycle in MCF-7 and MCF-7/Dox cells exposed to conventional and liposomal forms of doxorubicin.
    Rusetskaya NV; Lukyanova NY; Chekhun VF
    Exp Oncol; 2009 Sep; 31(3):140-3. PubMed ID: 19783968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice.
    Truchet I; Jozan S; Guerrin M; Mazzolini L; Vidal S; Valette A
    Exp Cell Res; 2000 Feb; 254(2):241-8. PubMed ID: 10640422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs.
    Poliseno L; Mariani L; Collecchi P; Piras A; Zaccaro L; Rainaldi G
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):127-30. PubMed ID: 12172977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB; Zhou JH; Zuo MX; You QD
    Yao Xue Xue Bao; 2008 Aug; 43(8):811-8. PubMed ID: 18956773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
    Pidgeon GP; Kandouz M; Meram A; Honn KV
    Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels.
    Ruiz de Almodóvar C; Ruiz-Ruiz C; Muñoz-Pinedo C; Robledo G; López-Rivas A
    Oncogene; 2001 Oct; 20(48):7128-33. PubMed ID: 11704839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF; Barberi-Heyob M; Didelot C; Peyrat JP; Abecassis J; Millon R; Merlin JL
    Br J Cancer; 2000 Nov; 83(10):1380-6. PubMed ID: 11044365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 exerts a pRb-mediated cell cycle inhibitory function in HEC1B endometrial carcinoma cells.
    Crescenzi E; Palumbo G
    Gynecol Oncol; 2001 May; 81(2):184-92. PubMed ID: 11330947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.